TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2935349

Group type: EXPERIMENTAL
Intervention: Celiprolol (1, 1, 2, and 4 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Metoprolol (1.25, 1.25, 2.5, and 5.0 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Celiprolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Metoprolol vs Celiprolol
Number of subjects: 24
Study: 31702643

Group type: EXPERIMENTAL
Intervention: HT080 (500 mg) twice a day for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo twice a day for 12 weeks
Number of subjects: 100
Study: 28333516

Group type: EXPERIMENTAL
Intervention: Doctor-office collaborative care (DOCC)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 321
Study: 25308300

Group type: EXPERIMENTAL
Intervention: SRI=100% (complete revascularisation)
Number of subjects: 2618

Group type: EXPERIMENTAL
Intervention: SRI=50-99%
Number of subjects: 2618

Group type: EXPERIMENTAL
Intervention: SRI<50%
Number of subjects: 2618

Group type: EXPERIMENTAL
Intervention: SRI cut-off <80%
Number of subjects: 2618

Group type: EXPERIMENTAL
Intervention: SRI as an independent predictor of one-year mortality
Number of subjects: 2618

Group type: COMPARATOR
Intervention: rSS compared to SRI
Number of subjects: 2618
Study: 23192600

Group type: EXPERIMENTAL
Intervention: Poor sleep quality
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Daily Disturbances factor of PSQI
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Being married or partnered
Number of subjects: 107

Group type: COMPARATOR
Intervention: Age, education, gender, and daytime sleepiness
Number of subjects: 107
Study: 21311402

Group type: EXPERIMENTAL
Intervention: Nonoperative treatment
Number of subjects: 1171

Group type: COMPARATOR
Intervention: Surgical treatment (open discectomy)
Number of subjects: 1171
Study: 18648238

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 17164728

Group type: EXPERIMENTAL
Intervention: Sirolimus (10 mg loading dose followed by 3 mg/m²/day, target levels 10-15 ng/mL for 6 months, then 5-10 ng/mL thereafter)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cyclosporine (4 to 8 mg/kg/day, target levels 150-300 ng/mL for 6 months, then 100-200 ng/mL thereafter)
Number of subjects: 40
Study: 12626991

Group type: EXPERIMENTAL
Intervention: Hygrolife HME
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EdithFlex HME
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both HMEs
Number of subjects: 0
Study: 11740876

Group type: EXPERIMENTAL
Intervention: Breast pump
Number of subjects: 28

Group type: COMPARATOR
Intervention: Manual expression
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Breast pump (at home)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Manual expression (at home)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Breast pump (in hospital)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Manual expression (in hospital)
Number of subjects: 28
Study: 9407377

Group type: EXPERIMENTAL
Intervention: Saquinavir (SQV, Invirase) treatment
Number of subjects: 33

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) alone
Number of subjects: 33
Study: 8428855

Group type: EXPERIMENTAL
Intervention: Theophylline 300 mg twice a day (R1)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Salbutamol 4 mg tid (R2)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combination therapy (200/4mg, R3)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combination therapy (100/2mg, R4)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (calcium lactate 300 mg) tid (R5)
Number of subjects: 25
Study: 3309901

Group type: EXPERIMENTAL
Intervention: Ceruletide 0.3 microgram/kg b.wt. injected IM 30 min before lunch
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo injected IM 30 min before lunch
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ceruletide
Number of subjects: 14
Study: 31300213

Group type: EXPERIMENTAL
Intervention: Iodine-125 (125I) seeds
Number of subjects: 98

Group type: COMPARATOR
Intervention: Surgical clips
Number of subjects: 98
Study: 30389802

Group type: EXPERIMENTAL
Intervention: Tailored Feedback (TF)
Number of subjects: 1054

Group type: COMPARATOR
Intervention: Standard Leaflet (SL)
Number of subjects: 1054

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1054
Study: 27098449

Group type: EXPERIMENTAL
Intervention: Dietary feedback and weekly text messages
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Dietary feedback only
Number of subjects: 247

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 247
Study: 25707517

Group type: EXPERIMENTAL
Intervention: Mycophenolic acid (MPA)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Population pharmacokinetic model
Number of subjects: 70
Study: 23802840

Group type: EXPERIMENTAL
Intervention: Saxagliptin 2.5, 5 or 10 mg/day
Number of subjects: 1144

Group type: EXPERIMENTAL
Intervention: Saxagliptin plus metformin
Number of subjects: 1144

Group type: EXPERIMENTAL
Intervention: Saxagliptin
Number of subjects: 1144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1144
Study: 21449914

Group type: EXPERIMENTAL
Intervention: 2 mg risperidone
Number of subjects: 72
Study: 19468932

Group type: EXPERIMENTAL
Intervention: Predispositional engagement (Need for Cognition, Mindfulness, Openness to Experience)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activity engagement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognition (working memory, processing speed, divergent thinking, inductive reasoning, visuo-spatial processing)
Number of subjects: 0
Study: 16390852

Group type: EXPERIMENTAL
Intervention: Impaired renal function (estimated glomerular filtration rate <60 ml/min/1.73 m²) in men and women aged 65 years or older
Number of subjects: 6317

Group type: COMPARATOR
Intervention: Cardiovascular risk factors (smoking, obesity, blood lipid levels, high systolic blood pressure, hyperuricaemia)
Number of subjects: 6317

Group type: COMPARATOR
Intervention: Cardiovascular drug prescriptions (angiotensin-converting enzyme inhibitors and beta-blockers)
Number of subjects: 6317
Study: 15286545

Group type: EXPERIMENTAL
Intervention: Early percutaneous tracheotomy within 48 hours
Number of subjects: 120

Group type: COMPARATOR
Intervention: Delayed tracheotomy at days 14-16
Number of subjects: 120
Study: 10939683

Group type: EXPERIMENTAL
Intervention: Scopolamine (1.5 mg, transdermal patch)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclizine (50 mg tablet)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9293194

Group type: EXPERIMENTAL
Intervention: Dental history questionnaire
Number of subjects: 74

Group type: COMPARATOR
Intervention: Slides of dental procedures
Number of subjects: 74

Group type: COMPARATOR
Intervention: No manipulation (Control)
Number of subjects: 74
Study: 8421116

Group type: EXPERIMENTAL
Intervention: 0.05% sodium fluoride and 0.05% chlorhexidine rinse
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 47
Study: 2892545

Group type: EXPERIMENTAL
Intervention: Etintidine (400 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29941296

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 75

Group type: COMPARATOR
Intervention: Risperidone and Aripiprazole
Number of subjects: 75
Study: 27294877

Group type: EXPERIMENTAL
Intervention: Mandibular block anesthesia (group A; n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Local infiltration anesthesia (group B; n=10)
Number of subjects: 20
Study: 25000437

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.5%
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 5
Study: 23378456

Group type: EXPERIMENTAL
Intervention: Low-fat strawberry kefir
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-fat orange kefir
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-fat plain kefir
Number of subjects: 10

Group type: COMPARATOR
Intervention: Kefir (all types)
Number of subjects: 10

Group type: COMPARATOR
Intervention: White bread
Number of subjects: 10
Study: 19350339

Group type: EXPERIMENTAL
Intervention: Strontium ranelate treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 0
Study: 18242076

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: TACE
Number of subjects: 123
Study: 22078189

Group type: EXPERIMENTAL
Intervention: Mifepristone 25 mg twice daily on day 1 plus placebo 1 daily for 4 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mifepristone 25 mg twice daily on day 1 plus ethinyl estradiol (EE) 20 mcg daily for days 2-5
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15643104

Group type: EXPERIMENTAL
Intervention: Flutamide
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Flutamide plus Citalopram
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 12243210

Group type: EXPERIMENTAL
Intervention: Antipsychotics
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 11477920

Group type: EXPERIMENTAL
Intervention: Integrated traditional Chinese and Western medicine (TCM‐WM) therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Western medicine (WM) alone
Number of subjects: 30
Study: 8576842

Group type: EXPERIMENTAL
Intervention: Teicoplanin loading doses of 6 to 30 mg/kg, followed by once-a-day treatment of approximately the same doses over several weeks.
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: FPIA assay method
Number of subjects: 197
Study: 2909202

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEPO) 50, 100, or 150 IU/kg body weight
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEPO)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 782764

Group type: EXPERIMENTAL
Intervention: Vitamin A alcohol in oil-water emulsion
Number of subjects: 43

Group type: COMPARATOR
Intervention: Vitamin A alcohol in oil
Number of subjects: 43

Group type: COMPARATOR
Intervention: Vitamin A palmitate in oil-water emulsion
Number of subjects: 43

Group type: COMPARATOR
Intervention: Vitamin A palmitate in oil
Number of subjects: 43
Study: 11550727

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (CBT)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Behavioral weight control
Number of subjects: 219

Group type: COMPARATOR
Intervention: Standard counseling alone
Number of subjects: 219
Study: 30703258

Group type: EXPERIMENTAL
Intervention: BMS-986231 0.1, 0.33, 1, 3, 5, 10, and 15 μg/kg/min infused over 24 hours
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: BMS-986231 10 μg/kg/min infused over 48 hours
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 29509839

Group type: EXPERIMENTAL
Intervention: Same-day home-based ART initiation (n=138)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Usual care (n=140)
Number of subjects: 278
Study: 26895920

Group type: EXPERIMENTAL
Intervention: Protective lung ventilation (low tidal volume of 6 ml/kg with PEEP of 5 cmH2O)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional ventilation with alveolar recruitment maneuver (tidal volume of 10 ml/kg with inspiratory pressure of 40 cmH2O for 30s)
Number of subjects: 62
Study: 24313385

Group type: EXPERIMENTAL
Intervention: UV-VL sunscreen with iron oxide as a VL-absorbing pigment, SPF ≥ 50, used over 8 weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: UV-only broad-spectrum sunscreen, SPF ≥ 50, used over 8 weeks
Number of subjects: 68
Study: 22562082

Group type: EXPERIMENTAL
Intervention: Autologous SCT
Number of subjects: 105

Group type: COMPARATOR
Intervention: Allogeneic SCT
Number of subjects: 105
Study: 20051131

Group type: EXPERIMENTAL
Intervention: Mental health nurse supplementary prescribing
Number of subjects: 45

Group type: COMPARATOR
Intervention: Independent medical prescribing
Number of subjects: 45
Study: 17355901

Group type: EXPERIMENTAL
Intervention: Chronic Disease Self-Management Program (CDSMP)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 139
Study: 15957991

Group type: EXPERIMENTAL
Intervention: Temporising treatment of severe early onset pre-eclampsia
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control group I (born at the duration of pregnancy of the pre-eclamptic mother on admission)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control group II (born at the same gestational age as the infant of the pre-eclamptic mother)
Number of subjects: 193
Study: 12919267

Group type: EXPERIMENTAL
Intervention: Educational package on baby walker use
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Advice on walkers
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Current practice regarding walker discussions
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Knowledge of walker-related injuries
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Resources for discussing walkers
Number of subjects: 64
Study: 10396013

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 65
Study: 8984227

Group type: EXPERIMENTAL
Intervention: doxazosin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: moduretic
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: amlodipine
Number of subjects: 9
Study: 1767898

Group type: EXPERIMENTAL
Intervention: Continuous lumbar epidural infusion of morphine
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Continuous lumbar epidural infusion of fentanyl
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Intramuscular morphine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Prophylactic administration of loratadine
Number of subjects: 64
Study: 7332913

Group type: EXPERIMENTAL
Intervention: Elixophyllin SR capsules
Number of subjects: 20

Group type: COMPARATOR
Intervention: Theo-Dur tablets
Number of subjects: 20
Study: 30264972

Group type: EXPERIMENTAL
Intervention: FIFA 11+ injury prevention program (10 weeks, 2 sessions/week)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Regular futsal warm-ups (control group)
Number of subjects: 71
Study: 29742718

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Transcutaneous electric nerve stimulation (TENS)
Number of subjects: 51
Study: 25059332

Group type: EXPERIMENTAL
Intervention: Oral moisturising gel containing egg yolk antibodies against Candida albicans (anti‐CA IgY)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo oral moisturising gel without anti‐CA IgY
Number of subjects: 0
Study: 23868719

Group type: EXPERIMENTAL
Intervention: Portuguese speakers
Number of subjects: 0

Group type: COMPARATOR
Intervention: English speakers
Number of subjects: 0
Study: 22440906

Group type: EXPERIMENTAL
Intervention: Biocompatible solution
Number of subjects: 185

Group type: COMPARATOR
Intervention: Conventional solution
Number of subjects: 185
Study: 19514864

Group type: EXPERIMENTAL
Intervention: losartan 25mg/chlorthalidone 6.25 mg
Number of subjects: 131

Group type: COMPARATOR
Intervention: losartan 25 mg/hydrochlorothiazide 12.5 mg
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: losartan 25mg/chlorthalidone 12.5 mg
Number of subjects: 131

Group type: COMPARATOR
Intervention: losartan 50 mg/hydrochlorothiazide 12.5 mg
Number of subjects: 131
Study: 17688161

Group type: EXPERIMENTAL
Intervention: Bimanual coordination program (sport stacking)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 41
Study: 16008927

Group type: EXPERIMENTAL
Intervention: Video-thoracoscopy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Routine open thoracotomy
Number of subjects: 47
Study: 11985943

Group type: EXPERIMENTAL
Intervention: Probiotic supplement (50 ml curd containing Lactobacillus acidophilus)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Isocaloric supplement (control group)
Number of subjects: 100
Study: 9891891

Group type: EXPERIMENTAL
Intervention: 0.05% levocabastine (BID)
Number of subjects: 93

Group type: COMPARATOR
Intervention: 0.1% lodoxamide (QID)
Number of subjects: 93
Study: 7636683

Group type: EXPERIMENTAL
Intervention: Packaged rice-based oral rehydration solution (R-ORS)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard glucose-electrolyte oral rehydration solution (G-ORS)
Number of subjects: 300
Study: 2651490

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 367712

Group type: EXPERIMENTAL
Intervention: Acebutolol (400 to 800 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Methyldopa (500 to 1000 mg daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 30
Study: 31517745

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin administered 12 hours before the operation
Number of subjects: 121

Group type: COMPARATOR
Intervention: Low-molecular-weight heparin administered 1 hour before the operation
Number of subjects: 121
Study: 28008603

Group type: EXPERIMENTAL
Intervention: Chair Yoga
Number of subjects: 131

Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 131
Study: 26384014

Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation (CR)
Number of subjects: 2198

Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation (CR) in depressed patients
Number of subjects: 2198

Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation (CR) in non-depressed patients
Number of subjects: 2198
Study: 23421844

Group type: EXPERIMENTAL
Intervention: PREP delivered by clergy
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: PREP delivered by professionals
Number of subjects: 193

Group type: COMPARATOR
Intervention: Naturally occurring services
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: PREP
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Family-of-origin background
Number of subjects: 193
Study: 21157403

Group type: EXPERIMENTAL
Intervention: 200 mg sotrastaurin twice daily with standard-exposure tacrolimus (treatment B)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 200 mg sotrastaurin twice daily with reduced-exposure tacrolimus (treatment C)
Number of subjects: 216

Group type: COMPARATOR
Intervention: mycophenolic acid (MPA) with standard-exposure tacrolimus (treatment A)
Number of subjects: 216
Study: 19524401

Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography (DSE) at 20 microg/kg/min and peak stress
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography (DSE) at peak stress
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography (DSE) from 20 microg/kg/min to peak stress
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Changes in e' velocity and E/e' during DSE
Number of subjects: 219
Study: 17556790

Group type: EXPERIMENTAL
Intervention: Isotretinoin (Acutaneï) therapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oral or topical acne therapy (control group)
Number of subjects: 200
Study: 15453970

Group type: EXPERIMENTAL
Intervention: Subjects with brain damage (emotion task)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjects with brain damage (personality task)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neurologically normal subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lesion overlap analysis
Number of subjects: 0
Study: 11478339

Group type: EXPERIMENTAL
Intervention: AIDA simulator (active intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional educational methods (control group)
Number of subjects: 0
Study: 10223254

Group type: EXPERIMENTAL
Intervention: Unilateral brain lesions from pre- or perinatal strokes
Number of subjects: 40

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Left-hemisphere damage
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Right-hemisphere damage
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Parietal lobe involvement (regardless of lesion side)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lesion severity
Number of subjects: 40
Study: 8535679

Group type: EXPERIMENTAL
Intervention: Contact vaporization of the prostate using the SLT Nd:YAG laser with an MTRL10 6 mm tip under general anaesthesia
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Contact vaporization of the prostate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 10
Study: 2085581

Group type: EXPERIMENTAL
Intervention: Ultraset
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard spike
Number of subjects: 41
Study: 37060

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (0.1 and 0.25 mg in 1 ml solution)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (protective application before antigen inhalation)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Regular prophylactic application of ipratropium bromide
Number of subjects: 8

Group type: COMPARATOR
Intervention: Disodium cromoglycate
Number of subjects: 8
Study: 30350896

Group type: EXPERIMENTAL
Intervention: Block periodization (BP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional periodization (TRAD)
Number of subjects: 16
Study: 28923751

Group type: EXPERIMENTAL
Intervention: Mindfulness training (6 weeks)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control (wait-list)
Number of subjects: 71
Study: 25730227

Group type: EXPERIMENTAL
Intervention: Cesarean delivery for nonreassuring fetal heart rate (FHR)
Number of subjects: 1291

Group type: COMPARATOR
Intervention: Control group (labor for 2 hours or longer without cesarean for nonreassuring FHR)
Number of subjects: 1291
Study: 23911245

Group type: EXPERIMENTAL
Intervention: Laser Doppler flowmetry (LDF)
Number of subjects: 200